You are here: Home » News-CM » Companies » News
Business Standard

Glenmark Pharma appoints Dr. Yasir Rawjee as CEO for API business

Capital Market 

On 07 May 2019

Glenmark Pharmaceuticals Ltd., a research‐led global integrated pharmaceutical company, today announced that it has appointed Dr. Yasir Rawjee as the Chief Executive Officer of Glenmark Life Sciences Ltd, its subsidiary for the API (Active Pharmaceutical Ingredients) business.He has over 25 years of experience in the pharmaceutical industry. He has a Ph.D. in Chemistry from Texas A&M University, USA and holds a degree in B.Sc.(Tech.) from UDCT Mumbai, India.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 07 2019. 11:02 IST